Clinical Trial Update: Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating the effects of metformin and rosiglitazone versus no diabetic treatment in patients with metabolic syndrome and insulin resis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome

Drugs mentioned

• Rosiglitazone (rosiglitazone)
• metformin (metformin)

Snippet

Sponsor: J JESUS VENEGAS, MD | Conditions: Insulin Resistance | Phase 2, Phase 3 | Status: COMPLETED